Isobutylmethylxanthine Market In Global
IBMX is a widely-used non-specific inhibitor of cyclic AMP and cyclic GMP phosphodiesterases (PDE ... Read More
AICAR is a cell-permeable adenosine analog that is a selective activator of AMP-activated protein kinase (AMPK) in adipocytes and hepatocytes.
This report contains market size and forecasts of AICAR in global, including the following market information:
Global AICAR Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global AICAR Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five AICAR companies in 2021 (%)
The global AICAR market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of AICAR include Abcam, Merck, Cayman Chemical, Bio-Techne, AG Scientific, Beyotime, ApexBio Technology, Enzo Biochem and STEMCELL Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the AICAR manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AICAR Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global AICAR Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global AICAR Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global AICAR Market Segment Percentages, by Application, 2021 (%)
Research
Biopharmaceutical
Global AICAR Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global AICAR Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AICAR revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies AICAR revenues share in global market, 2021 (%)
Key companies AICAR sales in global market, 2017-2022 (Estimated), (Kg)
Key companies AICAR sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Merck
Cayman Chemical
Bio-Techne
AG Scientific
Beyotime
ApexBio Technology
Enzo Biochem
STEMCELL Technologies
BPS Bioscience
PeproTech
Selleck Chemicals
Santa Cruz Biotechnology
BioVision
Hello Bio
Focus Biomolecules
AG Scientific
IBMX is a widely-used non-specific inhibitor of cyclic AMP and cyclic GMP phosphodiesterases (PDE ... Read More
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is ... Read More
Geldanamycin is an antibiotic and a potent antitumor compound. It inhibits pp60src tyrosine kinas ... Read More
Tunicamycin is a mixture of homologous nucleoside antibiotic that inhibits N-linked glycosylatio ... Read More